Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence

Completed · Phase 2

Conditions studied: Opiate Dependence, HIV Infections

In brief

The major goal is to determine in patients entering buprenorphine treatment, the prevalence of specific sex-related HIV risk behaviors, their physician's screening of these behaviors and to evaluate the impact of risk reduction counseling.

Key facts

Study ID

NCT00548275

Run by

Yale University

People needed

22

Starts

2006-07-01

Expected to finish

2011-06-01

Last updated by the study team

2020-04-03

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects meeting DSM-IV criteria for current opioid dependence
• HIV risk behaviors

You may not qualify if…

• current dependence on benzodiazepines or sedatives
• current suicide or homicide risk
• current psychotic disorder or untreated major depression
• inability to read or understand English
• unstable medical problems

Where it is running

• Methadone Research Unit, The APT Foundation, Inc. — New Haven, Connecticut, United States
• Yale-New Haven Hospital — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.